| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8679739 | Thrombosis Research | 2017 | 5 Pages |
Abstract
Subcutaneous VTE prophylaxis is not administered more frequently than oral infectious diseases or cardiac prophylaxis and treatment medications. These data suggest that availability of an oral medication could improve the effectiveness of VTE prophylaxis in real world settings.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Victor O. Popoola, Farrah Tavakoli, Brandyn D. Lau, Matthew Lankiewicz, Patricia Ross, Peggy Kraus, Dauryne Shaffer, Deborah B. Hobson, Jonathan K. Aboagye, Norma A. Farrow, Elliott R. Haut, Michael B. Streiff,